The Challenge: Ineffective Medical Representative Engagement with Endocrinologists
Pharmaceutical companies struggle to effectively engage endocrinologists, impacting advancements in patient care and treatment innovation in endocrinology.
The Loss: Impact on Patient Care and Treatment Innovation
Suboptimal MR activities lead to delayed adoption of new endocrinological treatments and techniques, resulting in prolonged patient discomfort, higher treatment costs, and missed opportunities for early intervention.
Data reveals a direct correlation between effective engagement strategies and improved patient outcomes in endocrinology, underscoring the need for targeted approaches to enhance physician education and patient care.
The Solution: Innovating MR Engagement for Endocrinologists
Pixika AI introduces a state-of-the-art mobile app designed to optimize MR engagement with endocrinologists. Our platform utilizes advanced digital strategies, including personalized web-to-web and web-to-print solutions, to deliver targeted promotional inputs and educational resources.
We empower pharmaceutical companies to enhance their interactions with endocrinologists, accelerating the adoption of new treatments and improving patient outcomes.
Establishing Credibility
As pharmaceutical business growth experts, Pixika AI collaborates with over 70 top global healthcare companies, impacting approximately 500,000 doctors annually through digital and print initiatives. Our solutions have significantly contributed to achieving cumulative revenues of 9700 crores and maintaining an average rating of 4.1 stars from 75% repeat customers.